n/a
Article Publish Status: FREE
Abstract Title:

Botulinum toxin A (BT-A) versus low-level laser therapy (LLLT) in chronic migraine treatment: a comparison.

Abstract Source:

Arq Neuropsiquiatr. 2018 Oct ;76(10):663-667. PMID: 30427505

Abstract Author(s):

Luana Mazzacoratti Loeb, Rebeca Padrão Amorim, Maria da Graça Naffah Mazzacoratti, Fulvio Alexandre Scorza, Mario Fernando Prieto Peres

Article Affiliation:

Luana Mazzacoratti Loeb

Abstract:

OBJECTIVE: The aim of this work was to evaluate patients with chronic migraine treated with botulinum toxin A (BT-A) and compare this with low level laser therapy (LLLT), referencing: pain days, pain intensity, intake of drugs/self-medication, anxiety and sleep disorders.

METHODS: Patients were randomized into two groups: BT-A group (n = 18) and LLLT group (n = 18). Each patient kept three pain diaries: one before (baseline) (30 days), one during treatment (30 days) and one after the post-treatment phase (30 days). Repeated ANOVA plus the Bonferroni post-test, Student's t test, and factorial analysis were applied, and p<0.05 was accepted as significant.

RESULTS: Our data showed that both treatments were able to reduce headache days, acute medication intake and decrease the intensity of pain. Anxiety was reduced in the BT-A group, while sleep disturbance was reduced in the LLLT group.

CONCLUSION: Our data showed that both treatments can be used to treat chronic migraine, without notable differences between them.

Study Type : Human Study

Print Options


Key Research Topics

This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

© Copyright 2008-2024 GreenMedInfo.com, Journal Articles copyright of original owners, MeSH copyright NLM.